The latest update focuses on competition and vertical integration. What does it mean for the PBM industry?

While Congress moves closer to pharmacy benefit manager reform with new legislation pending, "achieving large reductions in prescription drug costs" will require a different approach, says the Brookings Institution.

As the U.S. struggles with the shortages, a group of Republican governors wrote a letter to Congressional leaders, citing shortfalls of critical meds like amoxicillin and called for added transparency in the pharmaceutical supply chain.

Amid a tight labor market, workforce challenges are exacerbated by congressional gridlock and the rise of artificial intelligence.

Widespread opioid abuse has become major factor for employers.

The Centers for Medicare & Medicaid Services sent a letter to Medicaid directors in all 50 states, requiring them to determine whether they have an eligibility systems issue that could cause children to be dis-enrolled from Medicaid.

Investment in transformation, technology, and talent emerge as top priorities.

Companies also shared how they're preparing for the health care challenges ahead.